Genomic medicine for kidney disease

EE Groopman, HM Rasouly, AG Gharavi - Nature Reviews Nephrology, 2018 - nature.com
Technologies such as next-generation sequencing and chromosomal microarray have
advanced the understanding of the molecular pathogenesis of a variety of renal disorders …

Clinical genetic screening in adult patients with kidney disease

E Cocchi, JG Nestor, AG Gharavi - Clinical Journal of the …, 2020 - journals.lww.com
Expanded accessibility of genetic sequencing technologies, such as chromosomal
microarray and massively parallel sequencing approaches, is changing the management of …

Genetics and genotype–phenotype correlations in Finnish patients with dilated cardiomyopathy

O Akinrinade, L Ollila, S Vattulainen… - European heart …, 2015 - academic.oup.com
Aims Despite our increased understanding of the genetic basis of dilated cardiomyopathy
(DCM), the clinical utility and yield of clinically meaningful findings of comprehensive next …

Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates

DL Bodian, E Klein, RK Iyer, WSW Wong… - Genetics in …, 2016 - nature.com
Purpose: To assess the potential of whole-genome sequencing (WGS) to replicate and
augment results from conventional blood-based newborn screening (NBS). Methods …

Exome sequencing covers> 98% of mutations identified on targeted next generation sequencing panels

H LaDuca, KD Farwell, H Vuong, HM Lu, W Mu… - Plos one, 2017 - journals.plos.org
Background With the expanded availability of next generation sequencing (NGS)-based
clinical genetic tests, clinicians seeking to test patients with Mendelian diseases must weigh …

Incidental findings with genomic testing: implications for genetic counseling practice

MI Roche, JS Berg - Current genetic medicine reports, 2015 - Springer
This paper summarizes the current controversies surrounding the identification and
disclosure of “incidental” or “secondary” findings from genomic sequencing and the …

Neurology individualized medicine: when to use next-generation sequencing panels

CJ Klein, TM Foroud - Mayo Clinic Proceedings, 2017 - Elsevier
Next-generation sequencing (NGS) is increasingly being applied to clinical testing. This
practice is predicted to grow especially in neurology clinics because many of their patients …

A multi-omics dataset of human transcriptome and proteome stable reference

S Lu, H Lu, T Zheng, H Yuan, H Du, Y Gao, Y Liu… - Scientific Data, 2023 - nature.com
The development of high-throughput omics technology has greatly promoted the
development of biomedicine. However, the poor reproducibility of omics techniques limits …

Identification of novel mutations in endometrial cancer patients by whole-exome sequencing

YS Chang, HD Huang, KT Yeh… - … journal of oncology, 2017 - spandidos-publications.com
The aim of the present study was to identify genomic alterations in Taiwanese endometrial
cancer patients. This information is vitally important in Taiwan, where endometrial cancer is …

Towards an accurate and robust analysis pipeline for somatic mutation calling

J Jin, Z Chen, J Liu, H Du, G Zhang - Frontiers in Genetics, 2022 - frontiersin.org
Accurate and robust somatic mutation detection is essential for cancer treatment, diagnostics
and research. Various analysis pipelines give different results and thus should be …